Effects of catalpol on the activity of human liver cytochrome P450 enzymes

References

• Basheer L, Kerem Z. (2015). Interactions between CYP3A4 and dietary polyphenols. Oxid Med Cell Longev 2015:854015.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Neerati P. (2018). The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects. Eur J Clin Pharmacol 74:91–7.
   PubMed Web of Science ®Google Scholar
• Deng YX, Zhang XJ, Shi QZ, et al. (2012). Anti-hyperglycemic effects and mechanism of traditional Chinese medicine Huanglian Wan in streptozocin-induced diabetic rats. J Ethnopharmacol 144:425–32.
   PubMed Web of Science ®Google Scholar
• Dong Z, Chen CX. (2013). Effect of catalpol on diabetic nephropathy in rats. Phytomedicine 20:1023–9.
   PubMed Web of Science ®Google Scholar
• Feng Y, Liu Z, Peng Y, et al. (2013). Validated LC-MS method for simultaneous quantitation of catalpol and harpagide in rat plasma: application to a comparative pharmacokinetic study in normal and diabetic rats after oral administration of Zeng-Ye-Decoction. Biomed Chromatogr 27:1503–10.
   PubMed Web of Science ®Google Scholar
• Grimm SW, Einolf HJ, Hall SD, et al. (2009). The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America. Drug Metab Dispos 37:1355–70.
   PubMed Web of Science ®Google Scholar
• Hao X, Yuan J, Xu Y, et al. (2017). In vitro inhibitory effects of pristimerin on human liver cytochrome P450 enzymes. Xenobiotica 1:16.
   Google Scholar
• Jeong HU, Kong TY, Kwon SS, et al. (2013). Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes. Molecules 18:10681–93.
   PubMed Web of Science ®Google Scholar
• Lang J, Li W, Zhao J, et al. (2017). Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes. Xenobiotica 47:849–55.
   PubMed Web of Science ®Google Scholar
• Lee SY, Lee JY, Kang W, et al. (2013). Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang. Food Chem Toxicol 51:343–9.
   PubMed Web of Science ®Google Scholar
• Leite PM, Martins MA, Castilho RO. (2016). Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy. Biomed Pharmacother 83:14–21.
   PubMed Web of Science ®Google Scholar
• Li AP. (2001). Screening for human ADME/Tox drug properties in drug discovery. Drug Discovery Today 6:357–66.
   PubMed Web of Science ®Google Scholar
• Li X, Wang K, Wei W, et al. (2013). In vitro metabolism of brucine by human liver microsomes and its interactions with CYP substrates. Chem Biol Interact 204:140–3.
   PubMed Web of Science ®Google Scholar
• Liu L, Sun S, Rui H, Li X. (2017). In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes. Pharm Biol 55:1868–74.
   PubMed Web of Science ®Google Scholar
• Lu R, Gu Y, Si D, Liu C. (2009). Quantitation of catalpol in rat plasma by liquid chromatography/electrospray ionization tandem mass spectrometry and its pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 877:3589–94.
   PubMed Web of Science ®Google Scholar
• Lv QL, Wang GH, Chen SH, et al. (2016). In Vitro and in Vivo Inhibitory Effects of Glycyrrhetinic Acid in Mice and Human Cytochrome P450 3A4. Int J Environ Res Public Health 13:84.
   Web of Science ®Google Scholar
• Meng Q, Liu K. (2014). Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters. Curr Drug Metab 15:791–807.
   PubMed Web of Science ®Google Scholar
• Monbaliu J, Gonzalez M, Bernard A, et al. (2016). In Vitro and in Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity. Drug Metab Dispos 44:1682–91.
   Google Scholar
• Pelkonen O, Turpeinen M, Hakkola J, et al. (2008). Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 82:667–715.
   PubMed Web of Science ®Google Scholar
• Peng Y, Wu H, Zhang X, et al. (2015). A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug-drug interaction evaluation. Xenobiotica 45:961–77.
   PubMed Web of Science ®Google Scholar
• Qi XY, Liang SC, Ge GB, et al. (2013). Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol 56:392–7.
   PubMed Web of Science ®Google Scholar
• Seervi M, Lotankar S, Barbar S, Sathaye S. (2016). Assessment of cytochrome P450 inhibition and induction potential of lupeol and betulin in rat liver microsomes. Drug Metab Pers Ther 31:115–22.
   PubMedGoogle Scholar
• Shen CY, Jiang JG, Yang L, et al. (2017). Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery. Br J Pharmacol 174:1395–425.
   PubMed Web of Science ®Google Scholar
• Srinivas NR. (2016). Clinical drug-drug interactions of bosentan, a potent endothelial receptor antagonist, with various drugs: Physiological role of enzymes and transporters. Gen Physiol Biophys 35:243–58.
   PubMed Web of Science ®Google Scholar
• Wang Q, Xing M, Chen W, et al. (2012). HPLC-APCI-MS/MS method for the determination of catalpol in rat plasma and cerebrospinal fluid: application to an in vivo pharmacokinetic study. J Pharm Biomed Anal 70:337–43.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhao J, Lang J. (2016). The effects of verapamil on the pharmacokinetics of curculigoside in rats. Pharm Biol 54:3001–8.
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Stevens JC. (1992). The human hepatic cytochromes P450 involved in drug metabolism. Critical Reviews in Toxicology 22:1–21.
   PubMed Web of Science ®Google Scholar
• Xu W, Deng Z, Guo H, Ling P. (2012). A rapid and sensitive determination of aucubin in rat plasma by liquid chromatography-tandem mass spectrometry and its pharmacokinetic application. Biomed Chromatogr 26:1066–70.
   PubMed Web of Science ®Google Scholar
• Xu J, Ma HY, Liang S, et al. (2017). The role of human cytochrome P450 2E1 in liver inflammation and fibrosis. Hepatol Commun 1:1043–57.
   PubMed Web of Science ®Google Scholar
• Yan Z, Caldwell GW. (2001). Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. Curr Top Med Chem 1:403–25.
   PubMedGoogle Scholar
• Yan G, Zhang H, Wang W, et al. (2017). Investigation of the influence of glycyrrhizin on the pharmacokinetics of celastrol in rats using LC-MS and its potential mechanism. Xenobiotica 47:607–13.
   PubMed Web of Science ®Google Scholar
• Yang XX, Hu ZP, Duan W, et al. (2006). Drug-herb interactions: eliminating toxicity with hard drug design. Curr Pharm Des 12:4649–64.
   PubMed Web of Science ®Google Scholar
• Zhang FL, He X, Zhai YR, et al. (2015). Mechanism-based inhibition of CYPs and RMs-induced hepatoxicity by rutaecarpine. Xenobiotica 45:978–89.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li J, Lei X, et al. (2016). Influence of Verapamil on Pharmacokinetics of Triptolide in Rats. Eur J Drug Metab Pharmacokinet 41:449–56.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li C, Zhang F. (2018). In vitro inhibitory effects of sophocarpine on human liver cytochrome P450 enzymes. Xenobiotica 1–14. Epub Ahead of Print. DOI:10.1080/00498254.2018.1468047
   PubMed Web of Science ®Google Scholar
• Zhang JW, Liu Y, Cheng J, et al. (2007). Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharm Sci 10:496–503.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ya G, Rui H. (2016a). Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein. Eur J Drug Metab Pharmacokinet 42:89–98.
   Web of Science ®Google Scholar
• Zhao M, Tao J, Qian D, et al. (2016). Simultaneous determination of loganin, morroniside, catalpol and acteoside in normal and chronic kidney disease rat plasma by UPLC-MS for investigating the pharmacokinetics of Rehmannia glutinosa and Cornus officinalis Sieb drug pair extract. J Chromatogr B Analyt Technol Biomed Life Sci 1009-1010:122–9.
   PubMed Web of Science ®Google Scholar
• Zhou J, Xu G, Ma S, et al. (2015). Catalpol ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by suppressing the JNK and NF-κB pathways. Biochem Biophys Res Commun 467:853–8.
   PubMed Web of Science ®Google Scholar
• Zia H, Murray GI, Vyhlidal CA, et al. (2015). CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation. Int J Exp Pathol 96:81–6.
   PubMed Web of Science ®Google Scholar